CERo Therapeutics Holdings Inc’s recent filing unveils that its 10% Owner YK Bioventures Opportunities G unloaded Company’s shares for reported $0.18 million on Dec 13 ’24. In the deal valued at $0.06 per share,2,998,908 shares were sold. As a result of this transaction, YK Bioventures Opportunities G now holds 13,005,169 shares worth roughly $5.2 million.
Then, YK Bioventures Opportunities G sold 1,614,541 shares, generating $113,018 in total proceeds. Upon selling the shares at $0.07, the 10% Owner now owns 16,004,077 shares.
Before that, YK Bioventures Opportunities G sold 1,343,801 shares. CERo Therapeutics Holdings Inc shares valued at $107,504 were divested by the 10% Owner at a price of $0.08 per share. As a result of the transaction, YK Bioventures Opportunities G now holds 17,618,618 shares, worth roughly $7.05 million.
Price Performance Review of CERO
On Monday, CERo Therapeutics Holdings Inc [NASDAQ:CERO] saw its stock fall -11.99% to $0.40. Over the last five days, the stock has lost -10.45%. CERo Therapeutics Holdings Inc shares have fallen nearly -93.33% since the year began. Nevertheless, the stocks have fallen -99.56% over the past one year. While a 52-week high of $98.58 was reached on 01/07/25, a 52-week low of $0.40 was recorded on 06/09/25. SMA at 50 days reached $0.6635, while 200 days put it at $6.0134.
Levels Of Support And Resistance For CERO Stock
The 24-hour chart illustrates a support level at 0.3933, which if violated will result in even more drops to 0.3867. On the upside, there is a resistance level at 0.4083. A further resistance level may holdings at 0.4167. The Relative Strength Index (RSI) on the 14-day chart is 31.35, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.0569, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 97.61%. Stochastics %K at 13.30% indicates the stock is a buying.
